{"nct_id":"NCT03875482","title":"A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2019-05-13","start_date_type":"ACTUAL","primary_completion_date":"2020-02-20","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}